Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Distribute Innovative Biosensors' Pathogen Test

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will manufacture and distribute a multiplex pathogen-detection test for Innovative Biosensors under an agreement announced Tuesday.

Specifically, the Thermo Fisher Air Quality Instruments business will manufacture IB's BioFlash Biological Aerosol Collection, Detection and Identification System. The multiplex test detects up to 21 pathogens in real-time. In addition, Thermo Fisher has a worldwide sales, marketing, and distribution license under the Thermo Scientific brand in certain markets for BioFlash and associated consumables.

Financial terms of the collaboration were not disclosed.

"Thermo Fisher's world class manufacturing capabilities will enable us to satisfy the growing market demand for the BioFlash, which offers the unique capability of sampling, collecting, and identifying airborne pathogens in three minutes," Joe Hernandez, IB President and CEO, said in a statement.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.